Efficacy of Guda Haritaki in the disintegration of pathogenesis of Vatarakta (Gout)- A single arm clinical trial
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- This study is expected to be helpful in the management of Vatarakta (Gout)
研究概览
简要总结
Vatarakta is Vata pradhan Tridoshaj Vyadhi and its main Dushya is Rakta. According to Acharya Sushrut "Akhorvishamiv krudham deham anusarpati" (in aggravated stage, it spreads in whole body like rat poison)
Gout is typically characterized by episodic acute and chronic arthritis and pain and swelling of first metatarsophalangeal joint initially, followed by involvement of other joints.
Hyperuricaemia leads to formation and deposition of monosodium urate crystals (MSU crystals) which advantageously deposits in bursa, joints, tendons and its spaces and eventually forms nodular swellings called tophi.
Vatarakta (Gout) is a common presentation with symptoms like severe pain, inflammation, burning sensation and tenderness in the affected joints.
Small joints of feet and hands are mainly affected in Gout.
Present study is aimed to evaluate the efficacy of Guda Haritaki with Guduchi Kashaya in Vatarakta (Gout)
Study type is interventional and study design is Single Arm Clinical Trial with sample size of 50 patients.
3gm of Haritaki along with 3gm of Guda will be given with 40 ml of Guduchi Kashaya, twice daily, before meals for 45 days.
This study is expected to be helpful in clinical management of Vatarakta (Gout)
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Clinically diagnosed patients of Vatarakta (Gout) with Hyperuricaemia and presenting with the classical sign and symptoms of Vatarakta (Gout) Subjects consenting to participate in the study.
排除标准
- •Subjects suffering from other systemic illnesses Subjects suffering from autoimmune diseases of the joints Pregnant and lactating women.
结局指标
主要结局
This study is expected to be helpful in the management of Vatarakta (Gout)
时间窗: 45 days
次要结局
- This study will provide cost effective, safe drug with lesser side effects(12 months)